Jinhe Biotechnology Co.Ltd(002688) (SZ Jinhe Biotechnology Co.Ltd(002688) , closing price: 5.19 yuan) announced on April 21 that Jinhe Biotechnology Co.Ltd(002688) plans to use its own funds to buy back some public shares in the form of centralized bidding transaction, all of which are used to implement equity incentive, and the maximum price of repurchased shares shall not exceed 7.5 yuan / share. The number of shares to be repurchased this time shall not be less than 16 million shares (inclusive) and not more than 26.67 million shares (inclusive), The specific number of shares to be repurchased shall be subject to the actual number of shares to be repurchased at the expiration of the repurchase period. The term of this share repurchase is within 12 months after the shareholders’ meeting deliberates and approves this plan.
From January to June 2021, Jinhe Biotechnology Co.Ltd(002688) ‘s operating revenue was composed of: veterinary chemicals accounted for 51.06%, Shenzhen Agricultural Products Group Co.Ltd(000061) processing industry accounted for 24.1%, veterinary biological products accounted for 16.73%, environmental protection business accounted for 3.58% and others accounted for 3.29%.
Jinhe Biotechnology Co.Ltd(002688) ‘s chairman is Wang Dongxiao, male, 70 years old, with a master’s degree background; The general manager is Xie Changxian, male, 60 years old, with a master’s degree background.
